First Time Loading...

BiVictriX Therapeutics PLC
LSE:BVX

Watchlist Manager
BiVictriX Therapeutics PLC Logo
BiVictriX Therapeutics PLC
LSE:BVX
Watchlist
Price: 12 GBX 4.35% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

BVX Price Targets Summary
BiVictriX Therapeutics PLC

Wall Street analysts forecast BVX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVX is 67.32 GBX with a low forecast of 66.66 GBX and a high forecast of 69.3 GBX.

Lowest
Price Target
66.66 GBX
456% Upside
Average
Price Target
67.32 GBX
461% Upside
Highest
Price Target
69.3 GBX
478% Upside
BiVictriX Therapeutics PLC Competitors:
Price Targets
CYTH
Cyclo Therapeutics Inc
117% Upside
4978
ReproCell Inc
89% Upside
DCPH
Deciphera Pharmaceuticals Inc
6% Upside
OCX
OncoCyte Corp
50% Upside
SPRO
Spero Therapeutics Inc
364% Upside
BMRN
Biomarin Pharmaceutical Inc
35% Upside
049960
Cell Biotech Co Ltd
369% Upside
MOR
MorphoSys AG
15% Downside

Revenue
Forecast

Revenue Estimate
BiVictriX Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
BiVictriX Therapeutics PLC

Operating Income forecast
is not available for
BiVictriX Therapeutics PLC

Net Income
Forecast

Net Income Estimate
BiVictriX Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BVX's stock price target?
Price Target
67.32 GBX

According to Wall Street analysts, the average 1-year price target for BVX is 67.32 GBX with a low forecast of 66.66 GBX and a high forecast of 69.3 GBX.